US prosthetics, othotics payment panel to rule in October
This article was originally published in Clinica
The Centers for Medicare and Medicaid Services (CMS) has set the dates for the first two meetings of its new negotiated rulemaking committee on payments for prosthetics and certain custom-fabricated orthotics. The panel of supplier group representatives and other potentially affected parties will meet inaugurally on October 1-3, and then again on October 29-31 to begin the task of achieving consensus so they can advise CMS on a proposed payment rule for these products.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.